High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. – Cost Effective Supplements

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/14732596

Conclusion of this study

These findings indicate that the efficacy of olanzapine and risperidone may be augmented using high-dose adjuvant glycine treatment and suggest that these atypical antipsychotics may affect NMDA receptor-mediated neurotransmission differently than clozapine.